-- 
Celgene’s Alkeran Extends Life in Eye-Cancer Patients in Study

-- B y   K r i s t e n   H a l l a m
-- 
2011-09-23T22:01:00Z

-- http://www.bloomberg.com/news/2011-09-23/celgene-s-alkeran-extends-life-in-eye-cancer-patients-in-study.html
Melphalan, the active ingredient in
 Celgene Corp. (CELG) ’s Alkeran, helped patients live longer after
cancer had spread from their eyes to their livers, according to
a study to be presented today at the European Multidisciplinary
Cancer Congress in  Stockholm .  To contact the reporter on this story:
Kristen Hallam in London at 
 khallam@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  